M&A TRANSACTION · 2022
Humana's Hospice Business (Kindred at Home Hospice) acquired by Clayton, Dubilier & Rice
$3.40B· 12.0x EBITDA
Target
Humana's Hospice Business (Kindred at Home Hospice)
Acquirer
Clayton, Dubilier & Rice
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$283.0M
Deal Value
$3.40B
EV/EBITDA
12.0x
Context
This $3.40B acquisition of Humana's Hospice Business (Kindred at Home Hospice) by Clayton, Dubilier & Rice sits in the hospice sub-vertical. The 12.0x EBITDA multiple paid in 2022 can be compared against the population median for hospice transactions of similar size on our Hospice valuation hub. Clayton, Dubilier & Rice is acquiring as a private equity buyer; see how PE acquirers typically price hospice businesses on our Hospice PE buyer-pool page.
Source
Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own hospice
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Humana's Hospice Business (Kindred at Home Hospice) acquisition.